Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products

Published:2019-02-19 Issue:7 Volume:321 Page:676
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Rollman Jeffrey Eric¹,Heyward James¹,Olson Lily¹,Lurie Peter²,Sharfstein Joshua¹³,Alexander G. Caleb¹⁴⁵

Affiliation:

1. Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

2. Center for Science in the Public Interest, Washington, DC

3. Office of Public Health Practice and Training, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

5. Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/7/676/17291439/jama_rollman_2019_oi_190004.pdf

Reference21 articles.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warning Labels as a Public Health Intervention: Effects and Challenges for Tobacco, Cannabis, and Opioid Medications;Annual Review of Public Health;2024-05-20

2. Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review;American Heart Journal Plus: Cardiology Research and Practice;2024-02

3. Transmucosal fentanyl-related opioid use disorder in a cancer survivor;Therapies;2024-02

4. Perioperative analgesic efficacy and adverse events of fentanyl in dentistry: A systematic review;Oral Diseases;2023-10-13

5. Physician experiences with and perceptions of risk evaluation and mitigation strategy programs with elements to assure safe use;PLOS ONE;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3